Tryptamine Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020
Period Ending	Sep '25 Sep 8, 2025	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021	2020
Market Capitalization	43	43	31	-	-	-	Upgrade
Market Cap Growth	-	40.42%	-	-	-	-	Upgrade
Enterprise Value	40	40	36	-	-	-	Upgrade
Last Close Price	0.03	0.03	0.02	-	-	-	Upgrade
PS Ratio	27.31	27.29	23.16	-	-	-	Upgrade
PB Ratio	7.24	7.24	5.47	-	-	-	Upgrade
P/TBV Ratio	7.49	7.48	5.85	-	-	-	Upgrade
EV/Sales Ratio	25.40	25.51	27.33	-	-	-	Upgrade
Debt / Equity Ratio	-	-	0.04	-0.56	-	-	Upgrade
Asset Turnover	0.22	0.22	-	-	-	-	Upgrade
Quick Ratio	8.28	8.28	3.69	0.23	1.52	19.72	Upgrade
Current Ratio	9.08	9.08	3.87	0.24	1.82	22.03	Upgrade
Return on Equity (ROE)	-92.06%	-92.06%	-	-	-295.89%	-286.37%	Upgrade
Return on Assets (ROA)	-45.59%	-45.59%	-	-185.67%	-142.79%	-148.30%	Upgrade
Return on Capital (ROIC)	-54.61%	-54.61%	-	-	-181.70%	-157.90%	Upgrade
Earnings Yield	-12.34%	-12.35%	-23.98%	-	-	-	Upgrade
FCF Yield	-18.29%	-18.30%	-23.42%	-	-	-	Upgrade
Buyback Yield / Dilution	-295.36%	-172.04%	-45.33%	-346.62%	-51.73%	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.